Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Genetic testing dilemmas
Genetic testing is used to determine the risk of a patient or patient’s offspring developing genetic diseases. This is done with DNA sequencing in adults and preimplantation genetic diagnosis (PDG) on embryos. These methods of genetic testing are effective means of determining the likelihood of developing diseases such as Huntington’s disease, a disease resulting from trinucleotide repeat on chromosome 4p16.3 that causes uncontrollable muscle movement and decrease in cognitive function. However, they only determine probability, which isn’t an entirely reliable means of knowing whether or not symptoms will arise. It is patients’ right to opt for genetic testing on their own DNA, although they are accepting a great risk by doing so. DNA is unique to each individual, present in each individual since conception, and influences who each individual is, so the information contained within it belongs to each patient, despite the risks. Such risks include DNA testing services providing results to potential employers or insurers, who can make decisions at the disadvantage of the patients if high disease probabilities are discovered. The results can also cause patients to react emotionally poorly and make negative changes to their lifestyles. Although risky, patients deserve the rights to take these risks if they choose to do so. Genetic testing is the testing of DNA in a patient’s blood in order to detect genetic disorders. This can be used to predict the disease risk of an embryo, an unborn infant, or a fully grown patient, including the individual’s risk of passing on a genetic disorder to offspring (National Institute of Health [NIH], 2013). To test adult patients, a blood sample is first taken from the patient and the DNA ... ... middle of paper ... ...on series episode]. In P. Apsell (Executive producer), Nova. Arlington, VA: PBS Lyons, R.H. (2004). How do we Sequence DNA? In A Primer in DNA Structure and Function. Retrieved from http://seqcore.brcf.med.umich.edu/doc/educ/dnapr/sequencing.html Mahdieh, N. & Rabbani B. (2013). An Overview of Mutation Detection Methods in Genetic Disorders. Iranian Journal of Pediatrics, 23(4), 375-388. PMCID: PMC3883366 National Institute of Health. (2014). HTT huntingtin [ Homo sapiens (human) ]. Retrieved from U.S. National Library of Medicine, Genetics Home References website: http://www.ncbi.nlm.nih.gov/gene/3064 National Institute of Health. (2013). Genetic Testing. Retrieved from U.S. National Library of Medicine, Medline Plus website: http://www.nlm.nih.gov/medlineplus/genetictesting.html Online Mendelian Inheritance in Man. (2014). HUNTINGTON DISEASE; HD. MIM number: 143100
The more we know about genetics and the building blocks of life the closer we get to being capable of cloning a human. The study of chromosomes and DNA strains has been going on for years. In 1990, the Unites States Government founded the Human Genome Project (HGP). This program was to research and study the estimated 80,000 human genes and determine the sequences of 3 billion DNA molecules. Knowing and being able to examine each sequence could change how humans respond to diseases, viruses, and toxins common to everyday life. With the technology of today the HGP expects to have a blueprint of all human DNA sequences by the spring of 2000. This accomplishment, even though not cloning, presents other new issues for individuals and society. For this reason the Ethical, Legal, and Social Implications (ELSI) was brought in to identify and address these issues. They operate to secure the individuals rights to those who contribute DNA samples for studies. The ELSI, being the biggest bioethics program, has to decide on important factors when an individual’s personal DNA is calculated. Such factors would include; who would have access to the information, who controls and protects the information and when to use it? Along with these concerns, the ESLI tries to prepare for the estimated impacts that genetic advances could be responsible for in the near future. The availability of such information is becoming to broad and one needs to be concerned where society is going with it.
Huntington's disease is a progressive brain disorder that is caused by a single defective gene on chromosome 4 — which is one of the 23 human chromosomes that carry a person’s entire genetic code (alz.org, 2013). This defect is dominant, w...
In conclusion, it is important for nurses to have proper training and information in the area of genetics and genomics so that it can be used in daily clinical practice (Thompson & Brooks, 2011). Using this information with clients and conducting a detailed genetic nursing assessment is a valuable component of being an effective health care provider and can help clients recognize, prevent, and/or treat diseases that are unique to their particular
What are the risks and limitations of genetic testing?. (2014, April 21). Genetics Home Reference, Retrieved from http://ghr.nlm.nih.gov/handbook/testing/riskslimitations
Genetic Screening is a medical test that examines ones DNA. It can find mutations in chromosomes, genes, and proteins. These tests can confirm or refute a suspected genetic condition that could become a serious problem for one in the future. They can also help figure out a persons probability of getting certain diseases or sicknesses like cancer or diabetes. ( What is Genetic Testing?, para 1) There is also carrier testing which can be used to see what diseases couples may carry before having children. (What are the benefits of genetic testing? Para 1)
There are several types of genetic tests that can give us a broad amount of information about ourselves, our parents and/or children (What is testing?). Personally, I see advantages and disadvantages to it. Anyone is able to find the probability of them having a disorder or disease and start dealing with before it gets to a lethal stage. For women, it is reassuring to know whether a disorder that they possess can be passed on to their children or not. They can also know whether their child is healthy or not before it is even born. It also impacts on how scientists deal with diseases since they are given a different output of the disease at its early stages and allows them to study it until a cure is found. But what happens when your private information goes public? People will be treated differently because of a high risk of having a cancer in the future. In your CV, your past experiences and your qualities will be accompanied by your genetics test results that inform the company whether you will be a risk to them in the future. A new kind of discrimination will be created in our society. A second major disadvantage to genetic testing is people using it for “superficial” purposes like changing children’s eye colors and other biological characteristics that should not be changes. Above the disadvantages are the benefits which are why I am all for the genetic testing for health-related purposes.
Andre, Claire, and Manuel Velazquez. "Genetic Screening in the Workplace."Genetic Screening in the Workplace. Santa Clara University, 1991. 25 Apr. 2014.
First, let's consider the situations in which genetic testing would be beneficial to patients. Genetic testing for diseases that are preventable or treatable could allow individuals to alter their lifestyles so as to treat the disease or reduce their risk of developing the disease. For instance, the E2 version of the APOE gene, which is found on chromosome 19, has been linked to heart disease (Ridley, 1999). Individuals who have two copies of the E2 gene are particularly sensitive to high-fat and high-cholesterol diets. Therefore, a genetic test to determine whether a person has the high-risk version of the APOE gene could inform a person of future health risks, thereby allowing the person to change his diet to help prev...
Genetic screening can be used to refer to any activity that locates or advises people about genetically connected diseases. The first large-scale genetic screening project began in the 1960's with the Guthrie test which tests infants for PKU (phenylketonuria) (Munson, 1996). Currently with the advances being made by the Human Genome project we are achieving a much more detailed understanding of the relationship between specific genes and diseases. Approximately nine hundred gene or gene markers have been linked to diseases (Munson, 1996). With all of the new information about our genes, the ability to develop tests to screen for these genes is becoming possible for a much larger number of diseases. Some of the current DNA tests available diagnose Adult polycystic kidney disease, Alpha-1-Antitrypsin deficiency, familial adenomatous polyposis, hemophilia, Huntington's disease, myotonic dystrophy, and familial breast cancer susceptibility (Munson, 1996). Many more tests are well on the way to being developed. With the possibility o...
Situations like Jacob's are now a relatively common with the advent of genetic screening. People can now look into their genetic make up to find out if they carry a deleterious gene or genetic predisposition to a disease. No longer must many people with high risk families worry about whether or not they may contract the same disease as their ancestors. Diseases and disorders such as Huntington chorea, Alzheimer's, Multiple Sclerosis, Muscular Dystrophy, Hemophilia, and some kinds of cancer such as breast, colon, thyroid, ovarian, and skin can now be identified on a particular gene and can likely predict the probability of disease onset. But with this technology comes many physiological and ethical problems. Within this paper, I will define genetic screening, look at the controversial ethical viewpoints, and give a brief overview to this situation.
The "Genetic Screening" Genetic Screening. NDSU,. Web. The Web. The Web.
As we approach the 21st century, we as a society are increasingly bombarded with technical advances. One such area of advancement is the research involved with the Human Genome Mapping Project (HGMP). HGMP is a multi-billion dollar world wide research collaboration interested in sequencing the entire human genome. Started on October 1, 1990, with a group of over 350 labs, and expected to finish within the next 5 to 7 years, the Human Genome Mapping Project has given rise to many important advancements and many discoveries about the genetic make-up of humans (Bylinsky, 1994). With these advances come many ethical questions and concerns. The ability to screen an individual for specific disease will, in the future, play a major role in each of our lives. Genetic screening is defined in Genethics, by Suzuki and Knudson (1990), as "the examination of the genetic constitution of an individual - whether a fetus, a young child or a mature adult - in search of clues to the likelihood that this person will develop or transmit a heritable defect or disease."
Coughlin, S. S. (2002). Future challenges for research on diagnostic tests: genetic tests and disease prevention. Journal of Epidemiology & Community Health, 56(5), 335-336. doi:10.1136/jech.56.5.335
Genetic screening, also known as genetic or genomic testing, has become a controversial method of discovering genetic mutations, anomalies, or differences that are pathological. According to a study conducted by Virginia Commonwealth University, 77 percent of Americans believe that genetic testing should be made accessible to the general public (Funk, Huff). Genetic testing, while a popular option for predicting the outcomes of genetics, has ethical implications related to prenatal diagnosis, predictive testing, and carrier testing.
Genetic testing can help people determine why they get cancer or other diseases. Genetic testing is recommended to people who have a family history of a genetic disease, have children who are born with genetic defects, and have gone through more than one miscarriage in the past. Though these te...